The world of glucose monitoring is undergoing a major transformation. For decades, diabetes management relied on finger-prick blood glucose tests, where users manually measured their glucose levels a few times each day. Today, however, Continuous Glucose Monitoring (CGM) systems are changing how we think about health monitoring, wearable technology, and even artificial intelligence.
In this presentation, Martin Peacock explores the science behind enzyme-based biosensors, the electrochemistry that powers glucose sensors, and why wearables are becoming one of the most exciting areas in healthcare technology.
A Tale of Two Glucose Sensors
To illustrate how far glucose monitoring has progressed, two technologies were demonstrated side-by-side:
- A traditional Self-Monitoring Blood Glucose (SMBG) meter requiring a finger-prick blood sample.
- A Continuous Glucose Monitor (CGM), specifically the Abbott FreeStyle Libre.
Although these devices appear very different, they rely on a common scientific foundation: electrochemical biosensing.
Both technologies use the enzyme glucose oxidase to detect glucose and generate an electrical signal proportional to glucose concentration. The difference is that a glucose strip provides a single measurement, whereas a CGM continuously measures glucose levels throughout the day.
How Does a Continuous Glucose Monitor Work?
A CGM contains a tiny filament inserted into the interstitial fluid beneath the skin.
Glucose diffuses from the blood into this fluid, where it reacts with an enzyme layer on the sensor. The reaction generates an electrochemical current, often measured in nanoamps, which is processed by onboard electronics and converted into a glucose reading.
Modern CGMs are much more than sensors. They combine:
- Electrochemistry
- Biochemistry
- Electronics
- Signal processing
- Calibration algorithms
- Wireless communications
- Data analytics
The number displayed on a smartphone is therefore the result of a sophisticated chain of measurement and computation.
The Electrochemistry Behind the Sensor
The performance of a glucose sensor begins with the electrode.
When a voltage is applied to an electrode, ions rearrange near the surface, generating what electrochemists call charging current.
Understanding charging current is critical because it affects:
- Sensor accuracy
- Signal stability
- Response time
- Measurement reproducibility
Using the Zimmer & Peacock 501 screen-printed electrode as an example, the presentation explored how electrode area, conductivity, capacitance, and mass transport influence sensor performance.
One of the most useful takeaways for researchers developing biosensors is that controlling electrode geometry and manufacturing consistency is often as important as the biological chemistry itself.
Michaelis-Menten: The Equation That Drives Biosensors
At the heart of most enzyme-based biosensors lies the Michaelis-Menten equation.
This equation describes how an enzyme reacts with a substrate such as glucose.
Initially, the sensor response increases linearly as glucose concentration increases. However, enzymes have a finite number of active sites and can only process a limited number of molecules at any moment.
Eventually, the enzyme becomes saturated.
When saturation occurs:
- Additional glucose no longer produces a proportional increase in signal.
- Sensor response starts to plateau.
- Measurement range becomes limited.
This phenomenon explains why commercial glucose sensors often contain barrier layers that intentionally restrict glucose transport to the enzyme. While this sounds counterintuitive, it extends the sensor's useful operating range.
Glucose Strips: A Masterclass in Simple Microfluidics
Before CGMs became mainstream, glucose strips dominated diabetes management.
Interestingly, glucose strips remain one of the best examples of practical microfluidics.
When a drop of blood touches the strip, capillary action automatically fills the sensing chamber. No pumps, valves, or moving parts are required.
Inside the strip:
- Blood fills a capillary channel.
- Glucose reacts with immobilized enzymes.
- Electrochemical reactions occur at the electrode surface.
- Current is generated and measured.
- The signal is converted into glucose concentration.
Despite their apparent simplicity, glucose strips represent decades of optimisation in materials science, manufacturing, electrochemistry, and biosensor design.
Why Continuous Monitoring Is Winning
One of the most striking demonstrations involved deliberately creating a measurement error.
A finger-prick glucose measurement was performed normally. Then a small amount of sugar from a cake was transferred to the finger before repeating the test.
The result?
The glucose meter returned an extremely high reading due to contamination.
The lesson was simple:
Finger-prick testing is highly dependent on correct user technique.
CGM systems are not immune to problems, but because they continuously collect data throughout the day, they are much less vulnerable to occasional user errors.
Instead of a handful of data points per day, users may receive hundreds of glucose readings, providing a far more complete picture of glucose behaviour.
Biosensors Are Becoming Data Platforms
The future of biosensors is not simply about measuring biomarkers.
The future is about understanding context.
A glucose graph may show that glucose increased, but it cannot explain why it increased.
Context comes from:
- Diet
- Exercise
- Sleep
- Stress
- Medication
- Overall wellness
This is why major technology companies and healthcare companies are increasingly combining CGMs with smart watches, smart rings, and digital health platforms.
The goal is no longer just measurement.
The goal is understanding.
AI and the Next Generation of Healthcare
Artificial intelligence is rapidly becoming part of healthcare, but the future extends beyond today's large language models.
Continuous biosensors generate enormous volumes of physiological data.
Future AI systems will increasingly focus on:
- Pattern detection
- Predictive modelling
- Health forecasting
- Automated decision support
- Closed-loop therapeutic systems
As glucose monitoring expands into lactate, hormones, and other biomarkers, intelligent interpretation of sensor data will become just as important as the sensors themselves.
What Comes Next?
The next generation of biosensor technology is already under development.
Emerging areas include:
- Continuous glucose monitoring
- Microneedle biosensors
- Multi-analyte wearables
- Implantable biosensors
- Automated insulin delivery systems
- AI-driven physiological monitoring
While traditional glucose strips remain important, the direction of travel is becoming increasingly clear.
Healthcare is moving towards technologies that are:
- Continuous
- Wearable
- Connected
- Intelligent
- Predictive
Conclusion
The journey from finger-prick glucose strips to modern Continuous Glucose Monitoring systems highlights how far enzyme-based biosensors have advanced.
What began as a simple electrochemical measurement has evolved into an ecosystem of wearable sensors, cloud-connected devices, advanced analytics, and increasingly intelligent healthcare systems.
For engineers, scientists, clinicians, and entrepreneurs, the opportunity is no longer simply to build better sensors.
The opportunity is to build systems that transform physiological data into actionable health insights.
Related Resources
🧪 Screen-Printed Electrodes
https://shop.zimmerpeacock.com/en-gb/collections/bare-electrodes
🧬 Biosensors
https://shop.zimmerpeacock.com/en-gb/pages/sensors
⚡ Biosensor Electronics
https://shop.zimmerpeacock.com/en-gb/products/biosensor-single-purpose-board
🧫 Chemical Solutions & Reagents
https://shop.zimmerpeacock.com/en-gb/collections/chemical-and-solutions
🧪 Solutions for Screen-Printed Electrodes
https://shop.zimmerpeacock.com/en-gb/collections/solutions